News
For Physics Postdoc, New Evidence of Things Not Seen
For more than two decades, Fermilab in Batavia, Ill., housed the world’s largest particle accelerator — the Tevatron Collider — which allowed scientists to study the most elementary units of matter. Last September, Fermilab shut down the Tevatron forever. International hopes of understanding some of the most fundamental mysteries of particle physics began to shift […]
March 11, 2012
3Qs: It May Be Daylight Saving, But We’re Losing an Hour
By Casey Bayer This weekend we turn the clocks forward an hour for the return of daylight saving time, which means we lose an hour of sleep. We also have to do things an hour earlier than we did before relative to the natural light and dark cycles of the day and relative to our […]
March 09, 2012
Mapping the Depths of the Earth
As they drove through the Okavengo Delta in Botswana, a team of Woods Hole Oceanographic Institute (WHOI) scientists and three Northeastern physics students encountered a wild elephant attempting to protect his home from the unlikely intruders.
March 05, 2012
Mapping The Depths Of The Earth
By Angela Herring As they drove through the Okavengo Delta in Botswana, a team of Woods Hole Oceanographic Institute (WHOI) scientists and three Northeastern physics students encountered a wild elephant attempting to protect his home from the unlikely intruders. Undeterred, the team ventured on to obtain a single GPS point along the East African Rift, which […]
March 02, 2012
3Qs: ‘Leaping’ Into The Realm of Science
By Casey Bayer Murray Gibson (center), dean of the College of Science, says that without a leap day every fourth year, summer would drift out of sync about one month every 100 years or so. Today is Feb. 29, the extra day we add to the calendar in leap years. But why do we need […]
February 29, 2012
3Qs: Analyzing Why Sudden Drug Shortages Occur
By Matt Colette Graham Jones, chair of the chemistry and chemical biology department, says tough FDA standards and slim profit margins for certain pharmaceuticals mean drug shortages are likely, and the global market may worsen the problem. Photo by Mary Knox Merrill. Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to […]
February 27, 2012
Packing A ‘Super’ Punch
By Greg St. Martin Northeastern hosted a lecture on Sunday on the physics of superheroes’ powers ahead of the American Physical Society’s annual meeting in Boston. Over the years, superhero stories have delighted millions of fans through movies, television shows and comic books. But these tales can also teach us a lesson in physics, according […]
February 27, 2012
3Qs: Analyzing ‘Linsanity’
By Jason Kornwitz Two weeks ago, boxer Floyd Mayweather Jr. caused a stir by tweeting, “Jeremy Lin is a good player, but all the hype is because he’s Asian…” How much of the attention surrounding Lin stems from the fact that the first Asian-American NBA player of Chinese or Taiwanese descent has experienced a historic […]
February 27, 2012
A Pioneering Partnership To Cure Cystic Fibrosis
by Matt Collette Northeastern University and the Flatley Discovery Lab, a Boston-based independent, nonprofit organization, are collaborating to develop a cure for cystic fibrosis, a devastating genetic disease often overlooked by major pharmaceutical companies. Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis conductance regulator (CFTR) gene that cause thick, sticky mucus to […]
February 22, 2012
What is Network Science?
Distinguished Professor of Physics Albert-László Barabási discusses Network Science...
February 22, 2012
The Scales of Human Morality
by Angela Herring “In reality, we rationalize. We deny, or we couldn’t go on living,” says Judah Rosenthal, the successful ophthalmologist whose perfect life begins to unravel in Woody Allen’s 1989 film, “Crimes and Misdemeanors.” In order to go on living, Rosenthal must rationalize the series of risky and uncharacteristic decisions that nearly destroy him. Discussing […]
February 21, 2012
Laser Show—for a Cure
The naturally occurring antibiotic Actinomycin D (ActD) was approved by the Food and Drug Administration as a chemotherapy drug in 1964 and has been widely used for nearly 50 years to treat a variety of tumor types. Since then, scientists have discovered that ActD works by blocking DNA transcription, the process that transcribes DNA into RNA, a macromolecule that codes for the proteins necessary for cell survival.
February 21, 2012
FDA Releases Draft Guidelines For Biosimilar Approval Pathway
Northeastern University Provides Input on Regulatory Standards The FDA recently released draft guidelines for the Biosimilar Approval Pathway, which will accelerate the approval process for biosimilars—the generic versions of biopharmaceuticals. These guidelines will give drug companies who are producing these generic drugs the opportunity to enter the market rapidly. Since 2009 Northeastern University has been […]
February 19, 2012